| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |